Literature DB >> 20508781

HPV Vaccination and Testing.

Athol Kent1.   

Abstract

Year:  2010        PMID： 20508781      PMCID： PMC2876324     

Source DB:  PubMed          Journal:  Rev Obstet Gynecol        ISSN： 1941-2797


× No keyword cloud information.
  5 in total

1.  Cervical cancer: problem solved? Vaccinating girls against human papillomavirus.

Authors:  E J Crosbie; L Brabin
Journal:  BJOG       Date:  2010-01       Impact factor: 6.531

2.  Cervical-cancer screening--new guidelines and the balance between benefits and harms.

Authors:  George F Sawaya
Journal:  N Engl J Med       Date:  2009-11-25       Impact factor: 91.245

3.  Global access to HPV vaccination: what are we waiting for?

Authors:  Gary M Clifford
Journal:  Lancet       Date:  2009-12-12       Impact factor: 79.321

4.  ACOG Practice Bulletin no. 109: Cervical cytology screening.

Authors: 
Journal:  Obstet Gynecol       Date:  2009-12       Impact factor: 7.661

5.  Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years.

Authors:  B Romanowski; P Colares de Borba; P S Naud; C M Roteli-Martins; N S De Carvalho; J C Teixeira; F Aoki; B Ramjattan; R M Shier; R Somani; S Barbier; M M Blatter; C Chambers; D Ferris; S A Gall; F A Guerra; D M Harper; J A Hedrick; D C Henry; A P Korn; R Kroll; A-B Moscicki; W D Rosenfeld; B J Sullivan; C S Thoming; S K Tyring; C M Wheeler; G Dubin; A Schuind; T Zahaf; Mary Greenacre; An Sgriobhadair
Journal:  Lancet       Date:  2009-12-12       Impact factor: 79.321
  5 in total
  13 in total

1.  TUC338 promotes cell migration and invasion by targeting TIMP1 in cervical cancer.

Authors:  Qin Li; Feiyang Shen; Chenghai Wang
Journal:  Oncol Lett       Date:  2017-04-03       Impact factor: 2.967

2.  Trends in gynaecological cancers in the largest obstetrics and gynaecology hospital in China from 2003 to 2013.

Authors:  XueLian Li; SaiHua Zheng; ShangJie Chen; Feng Qin; Sandy Lau; Qi Chen
Journal:  Tumour Biol       Date:  2015-02-04

3.  Pattern of gynaecological malignancies in south western region of Pakistan: An overview of 12 years.

Authors:  Hina Manzoor; Hamida Naheed; Khushnaseeb Ahmad; Shehla Iftikhar; Muhammad Asif; Jamila Shuja; Neelam Sultan; Irfan Ali; Syed Inayatullah; Yasir Hayat Khan
Journal:  Biomed Rep       Date:  2017-09-28

4.  Overexpression of ezrin and galectin-3 as predictors of poor prognosis of cervical cancer.

Authors:  M Li; Y M Feng; S Q Fang
Journal:  Braz J Med Biol Res       Date:  2017-03-23       Impact factor: 2.590

5.  Influencing factors on cervical cancer screening from the Kurdish women's perspective: A qualitative study.

Authors:  V H Rasul; M A Cheraghi; Z Behboodi Moqadam
Journal:  J Med Life       Date:  2015

6.  Emerging role of mutations in epigenetic regulators including MLL2 derived from The Cancer Genome Atlas for cervical cancer.

Authors:  Xia Li
Journal:  BMC Cancer       Date:  2017-04-08       Impact factor: 4.430

7.  CDK7 inhibitor suppresses tumor progression through blocking the cell cycle at the G2/M phase and inhibiting transcriptional activity in cervical cancer.

Authors:  Shanshan Zhong; Yi Zhang; Xia Yin; Wen Di
Journal:  Onco Targets Ther       Date:  2019-03-22       Impact factor: 4.147

8.  Prevalence of HPV Genotypes in South Europe: Comparisons between an Italian and a Turkish Unvaccinated Population.

Authors:  Maria Teresa Schettino; Pasquale De Franciscis; Antonio Schiattarella; Viviana La Manna; Alessandra Della Gala; Francesca Caprio; Carolina Tammaro; Franco Pietro Ammaturo; Tolga Guler; Ezgi Hanci Yenigün
Journal:  J Environ Public Health       Date:  2019-05-19

9.  A Functional Polymorphism in the Promoter of MiR-143/145 Is Associated With the Risk of Cervical Squamous Cell Carcinoma in Chinese Women: A Case-Control Study.

Authors:  Yundan Liang; Ruifen Sun; Lijuan Li; Fang Yuan; Weibo Liang; Li Wang; Xinwen Nie; Peng Chen; Lin Zhang; Linbo Gao
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.889

10.  microRNA-214 suppresses the growth of cervical cancer cells by targeting EZH2.

Authors:  Yanling Yang; Yang Liu; Guilin Li; Lei Li; Peng Geng; Hongjuan Song
Journal:  Oncol Lett       Date:  2018-08-24       Impact factor: 2.967
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.